Results 261 to 270 of about 606,113 (313)
Some of the next articles are maybe not open access.
Hepatitis B virus immunopathology
Springer Seminars in Immunopathology, 1995Approximately 5% of the world population is infected by the hepatitis B virus (HBV) which causes a necroinflammatory liver disease of variable duration and severity. Chronically infected patients with active liver disease carry a high risk of developing cirrhosis and hepatocellular carcinoma.
Chisari, F. V, FERRARI, Carlo
openaire +2 more sources
The Lancet, 2009
Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma.
Yun-Fan, Liaw, Chia-Ming, Chu
openaire +2 more sources
Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma.
Yun-Fan, Liaw, Chia-Ming, Chu
openaire +2 more sources
The Nurse Practitioner, 1983
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Hepatitis B Virus Immunopathogenesis
Annual Review of Immunology, 1995Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that causes a necroinflammatory liver disease of variable duration and severity. Chronically infected patients with active liver disease carry a high risk of developing cirrhosis and hepatocellular carcinoma.
Chisari, F. V, FERRARI, Carlo
openaire +3 more sources
The Lancet, 2014
Hepatitis B virus infection is a major public health problem worldwide; roughly 30% of the world's population show serological evidence of current or past infection. Hepatitis B virus is a partly double-stranded DNA virus with several serological markers: HBsAg and anti-HBs, HBeAg and anti-HBe, and anti-HBc IgM and IgG.
Christian, Trépo +2 more
openaire +2 more sources
Hepatitis B virus infection is a major public health problem worldwide; roughly 30% of the world's population show serological evidence of current or past infection. Hepatitis B virus is a partly double-stranded DNA virus with several serological markers: HBsAg and anti-HBs, HBeAg and anti-HBe, and anti-HBc IgM and IgG.
Christian, Trépo +2 more
openaire +2 more sources
Baillière's Clinical Gastroenterology, 1990
Of all the hepatotropic viruses, HBV is associated with the greatest worldwide morbidity and mortality. This is because of the ease of transmission and the potential for progression to a chronic infective carrier state, with the complications of cirrhosis and hepatocellular carcinoma.
J L, Brown, W F, Carman, H C, Thomas
openaire +2 more sources
Of all the hepatotropic viruses, HBV is associated with the greatest worldwide morbidity and mortality. This is because of the ease of transmission and the potential for progression to a chronic infective carrier state, with the complications of cirrhosis and hepatocellular carcinoma.
J L, Brown, W F, Carman, H C, Thomas
openaire +2 more sources
New England Journal of Medicine, 2008
More effective and less resistance-prone antiviral agents are now available to treat hepatitis B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and reverse the progression of chronic HBV infection is important, given the evidence linking high-level HBV replication and the late consequences of chronic HBV infection ...
openaire +2 more sources
More effective and less resistance-prone antiviral agents are now available to treat hepatitis B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and reverse the progression of chronic HBV infection is important, given the evidence linking high-level HBV replication and the late consequences of chronic HBV infection ...
openaire +2 more sources
Hepatic Expression of Hepatitis B Virus Genome in Chronic Hepatitis B Virus Infection
American Journal of Clinical Pathology, 1996The expression of hepatitis B virus (HBV) DNA in the liver was studied by nonisotopic in situ hybridization and correlated with liver histology, different phases in the natural evolution of chronic hepatitis B, and hepatic expression of HBV antigens in 251 Chinese patients with chronic HBV infection.
Fang, JWS +6 more
openaire +3 more sources
Hepatitis B Virus and Cryoglobulinemia
Annals of Internal Medicine, 1981Excerpt To the editor: Dr. Levo (1) refers in his comment on the paper by Popp and colleagues (2) to our data (3) in support of the hypothesis of a significant correlation between hepatitis B virus...
M. Galli, F. Invernizzi
openaire +3 more sources
Occult hepatitis B virus infection
Digestive and Liver Disease, 2000Many studies have shown that hepatitis B virus infection may also occur in hepatitis B surface antigen-negative patients. This occult infection has been identified both in patients with cryptogenic liver disease and in patients with hepatitis C virus-related chronic hepatitis, and much evidence suggests that it may be a risk factor of hepatocellular ...
RAIMONDO, Giovanni +8 more
openaire +8 more sources